美国先灵葆雅  Schering-Plough Corporation   
先灵葆雅是一家世界著名的以科研为基础的国际性制药公司，在全球20多个国家建有工厂，40多个国家和地区设有附属公司，125个地区上市销售处方药、非处方药及兽药，总部设在美国新泽西州麦迪逊市。先灵葆雅在全球上市的产品种类包括：血液、肿瘤、肝炎、呼吸／过敏、抗感染、皮肤、心血管等不同领域。

目前，公司在中国上市的主要产品有：开瑞能、开瑞坦、荷洛松、艾洛松、甘乐能（干扰能）、先特能（生白能）、力确兴、葆乐辉等。
 

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each day on becoming a champion for our stakeholders.
During the past five years, Schering-Plough has been building a new kind of health care company. Throughout Schering-Plough, there’s a desire to build long-term relationships with our stakeholders based on mutual confidence. This is evident in many ways. Our scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and well-being of people around the world. Our sales professionals, marketing teams, colleagues working at our plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust.
All of this takes hard work, sharp execution, integrity and transparency on the part of Schering-Plough’s colleagues. Our global team is working to sustain and expand innovative new treatments. We’re determined to do our part to increase access to better health care for all people. And, we are focused on becoming the best in three key strategic areas: people, products and processes.
We’re beginning to see the results of our efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From our perspective as a health care company, that means helping people around the world live better and live longer.